Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Pharmacokinetic“
Suchtreffer
Begriffe & Kennungen
Aloxi · 4.5 · Metoclopramide In a clinical study, no significant pharmacokinetic interaction was shown between a single intr
Eintrag öffnenAlymsys · 4.5 · Effect of antineoplastic agents on bevacizumab pharmacokinetics
Eintrag öffnenAlymsys · 4.5 · Effect of bevacizumab on the pharmacokinetics of other antineoplastic agents
Eintrag öffnenAlymsys · 4.5 · No clinically relevant interaction of bevacizumab was observed on the pharmacokinetics of co-administered inte
Eintrag öffnenAlymsys · 4.5 · No clinically relevant interaction of co-administered chemotherapy on bevacizumab pharmacokinetics was observe
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.5 · Ambrisentan had no effects on the steady-state pharmacokinetics and anti-coagulant activity of warfarin in a h
Eintrag öffnenAmifampridine SERB · 4.5 · Pharmacokinetic interactions
Eintrag öffnenAmlodipine / Valsartan Mylan · 4.5 · Others In clinical interaction studies, amlodipine did not affect the pharmacokinetics of atorvastatin, digoxi
Eintrag öffnenAnagrelide Viatris (previously Anagrelide Mylan) · 4.5 · Limited pharmacokinetic and/or pharmacodynamic studies investigating possible interactions between anagrelide
Eintrag öffnenAnoro Ellipta (previously Anoro) · 4.5 · Umeclidinium is a substrate of cytochrome P450 2D6 (CYP2D6). The steady-state pharmacokinetics of umeclidinium
Eintrag öffnenApexelsin · 4.5 · A pharmacokinetic study was conducted with human serum albumin-paclitaxel nanoparticles and carboplatin in non
Eintrag öffnenApidra · 4.5 · Studies on pharmacokinetic interactions have not been performed. Based on empirical knowledge from similar med
Eintrag öffnenApixaban Accord · 4.5 · Other concomitant therapies No clinically significant pharmacokinetic or pharmacodynamic interactions were obs
Eintrag öffnenApixaban Accord · 4.5 · Other concomitant therapies No clinically significant pharmacokinetic or pharmacodynamic interactions were obs
Eintrag öffnenApixaban Accord · 4.5 · Pharmacokinetic or pharmacodynamic interactions were not evident when apixaban was coadministered with ASA 325
Eintrag öffnenApixaban Accord · 4.5 · Pharmacokinetic or pharmacodynamic interactions were not evident when apixaban was coadministered with ASA 325
Eintrag öffnenApretude · 4.5 · Effect of cabotegravir on the pharmacokinetics of other medicinal products
Eintrag öffnenApretude · 4.5 · Effect of cabotegravir on the pharmacokinetics of other medicinal products
Eintrag öffnenApretude · 4.5 · Effect of other agents on the pharmacokinetics of cabotegravir
Eintrag öffnenApretude · 4.5 · Effect of other medicinal products on the pharmacokinetics of cabotegravir
Eintrag öffnen